{"article_link": "https://www.frontiersin.org/articles/10.3389/fgene.2020.616435/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/sra/SRP237545", "format": "fastq", "source": "Sequence Read Archive (SRA)", "public_id": "SRP237545"}, {"id": "data_2", "omics": "Proteomics", "link": "", "format": "", "source": "", "public_id": ""}, {"id": "data_3", "omics": "Metabolomics", "link": "", "format": "", "source": "", "public_id": ""}], "analyses": [{"id": "analysis_1", "analysis_type": "RNA-seq", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["early stage DN", "control"]}}, {"id": "analysis_2", "analysis_type": "Differential analysis", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["early stage DN", "control"]}}, {"id": "analysis_3", "analysis_type": "Differential analysis", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["advanced-stage DN", "control"]}}, {"id": "analysis_4", "analysis_type": "Weighted correlation network analysis (WGCNA)", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["early stage DN", "advanced-stage DN", "control"]}}, {"id": "analysis_5", "analysis_type": "KEGG enrichment analysis", "analysis_data": ["analysis_4"], "training_set": [], "test_set": [], "label": {"module": ["turquoise", "blue"]}}, {"id": "analysis_6", "analysis_type": "Protein quantification", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_7", "analysis_type": "Differential analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_8", "analysis_type": "Gene Set Enrichment Analysis (GSEA)", "analysis_data": ["analysis_7"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_9", "analysis_type": "Protein–protein functional network analysis", "analysis_data": ["analysis_7"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_10", "analysis_type": "Metabolite profiling", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_11", "analysis_type": "Principal Component Analysis (PCA)", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_12", "analysis_type": "Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA)", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_13", "analysis_type": "Differential analysis", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_14", "analysis_type": "KEGG pathway enrichment", "analysis_data": ["analysis_13"], "training_set": [], "test_set": [], "label": {"group": ["db/db", "db/m"]}}, {"id": "analysis_15", "analysis_type": "Differential analysis", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["early stage DN", "advanced-stage DN"]}}, {"id": "analysis_16", "analysis_type": "KEGG pathway enrichment", "analysis_data": ["analysis_15"], "training_set": [], "test_set": [], "label": {"group": ["early stage DN", "advanced-stage DN"]}}], "results": [{"analysis_id": "analysis_1", "metric": "PCA segregation", "value": "Advanced-stage DN samples significantly segregated from controls", "features": []}, {"analysis_id": "analysis_2", "metric": "fold change", "value": "115 up-regulated genes, 193 down-regulated genes (fold change > 2 or < 0.5, p < 0.05)", "features": ["CXCL12", "IL-6", "CXCL8", "CCL20", "CXCL1", "IL1B", "MIR29A", "MIR4521", "PABPC5-AS1", "AL353600.2"]}, {"analysis_id": "analysis_3", "metric": "fold change", "value": "3,135 up-regulated genes, 1,372 down-regulated genes (fold change > 2 or < 0.5, p < 0.05)", "features": ["IL-6", "CXCL3", "CCL5", "CYP26B1", "CYP4A22", "COX5BP1"]}, {"analysis_id": "analysis_4", "metric": "correlation", "value": "Turquoise module (R = 0.80, p < 0.001), Blue module (R = 0.63, p < 0.001), Brown module (R = 0.67, p < 0.001)", "features": ["Turquoise module (3,143 genes): ECM construction, inflammatory pathways", "Blue module (1,282 genes): Metabolic pathways", "Brown module (104 genes): Early stage DN"]}, {"analysis_id": "analysis_5", "metric": "enrichment", "value": "Significant pathways in turquoise and blue modules", "features": ["Cytokine–cytokine receptor interaction", "JAK-STAT signaling pathway", "T cell receptor signaling pathway", "ECM construction", "Retinol metabolism", "Glucagon signaling pathway", "Glycine, serine and threonine metabolism", "Linoleic acid metabolism", "Fat digestion and absorption", "Oxidative phosphorylation", "Drug metabolism"]}, {"analysis_id": "analysis_6", "metric": "PCA segregation", "value": "Db/db samples significantly segregated from db/m controls", "features": []}, {"analysis_id": "analysis_7", "metric": "fold change", "value": "210 up-regulated proteins, 119 down-regulated proteins (fold change > 2 or < 0.5, p < 0.05)", "features": ["Cox2", "Acox1", "Acox2", "Acox3", "Acms1", "Acms3"]}, {"analysis_id": "analysis_8", "metric": "enrichment", "value": "Significant pathways in db/db group", "features": ["Fatty-acids metabolism", "Fatty-acids β-oxidation", "Fatty-acids biosynthesis"]}, {"analysis_id": "analysis_9", "metric": "network analysis", "value": "Co-inhibited fatty-acid metabolism enzymes", "features": ["Cox2", "Acox1", "Acox2", "Acox3", "Acms1", "Acms3"]}, {"analysis_id": "analysis_10", "metric": "PCA segregation", "value": "Db/db metabolomes significantly segregated from db/m controls", "features": []}, {"analysis_id": "analysis_11", "metric": "PCA segregation", "value": "Distinct metabolomic profiles between db/db and db/m", "features": []}, {"analysis_id": "analysis_12", "metric": "modeling", "value": "Significant discrimination between db/db and db/m", "features": []}, {"analysis_id": "analysis_13", "metric": "fold change", "value": "28 up-regulated metabolites, 154 down-regulated metabolites (fold change > 2 or < 0.5, VIP > 1, p < 0.05)", "features": ["(±)10(11)-EpDPA", "(±)9-HpODE", "(±)13-HODE", "Linoleic Acid", "Docosahexaenoic acid"]}, {"analysis_id": "analysis_14", "metric": "enrichment", "value": "Significant pathways in db/db group", "features": ["Sphingolipid metabolism", "Biosynthesis of unsaturated fatty acids", "Alpha-linolenic acid metabolism"]}, {"analysis_id": "analysis_15", "metric": "fold change", "value": "32 up-regulated metabolites, 30 down-regulated metabolites (fold change > 2 or < 0.5, VIP > 1, p < 0.05)", "features": ["(±)9-HpODE", "Linoleic Acid"]}, {"analysis_id": "analysis_16", "metric": "enrichment", "value": "Significant pathways in advanced-stage DN", "features": ["Sphingolipid metabolism", "Linoleic acid metabolism"]}]}